GOALS OF WORK: The aim of the study was to explore the development of functioning impairments and symptom occurrence during the last months of life of advanced cancer patients. MATERIALS AND METHODS: Self-reported data from 116 patients who all completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) at 3, 2 and 1 month before death were analysed. MAIN RESULTS: All functioning aspects deteriorated. For physical, cognitive and social function, the most marked changes occurred between 2 and 1 month before death. The proportion reporting serious difficulties with self-care activities increased from 14% to 43%. The most seriously affected activity could not be distinguished from the EORTC QLQ-C30 scores. Levels of fatigue, dyspnoea and appetite loss increased significantly. More than 50% of the patients had severe pain at all assessments, and only a minor number (8%) reported any improvement. CONCLUSIONS: The findings have implications for the planning of care and indicate that further research is required to improve assessment, treatment and follow-up procedures. Adequate pain treatment seems still to be a challenge. Anorexia, fatigue as well as dyspnoea are all symptoms that need further focus.
GOALS OF WORK: The aim of the study was to explore the development of functioning impairments and symptom occurrence during the last months of life of advanced cancerpatients. MATERIALS AND METHODS: Self-reported data from 116 patients who all completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) at 3, 2 and 1 month before death were analysed. MAIN RESULTS: All functioning aspects deteriorated. For physical, cognitive and social function, the most marked changes occurred between 2 and 1 month before death. The proportion reporting serious difficulties with self-care activities increased from 14% to 43%. The most seriously affected activity could not be distinguished from the EORTC QLQ-C30 scores. Levels of fatigue, dyspnoea and appetite loss increased significantly. More than 50% of the patients had severe pain at all assessments, and only a minor number (8%) reported any improvement. CONCLUSIONS: The findings have implications for the planning of care and indicate that further research is required to improve assessment, treatment and follow-up procedures. Adequate pain treatment seems still to be a challenge. Anorexia, fatigue as well as dyspnoea are all symptoms that need further focus.
Authors: Raymond S K Lo; Jean Woo; Karen C H Zhoc; Charlotte Y P Li; Winnie Yeo; Philip Johnson; Yvonne Mak; Joseph Lee Journal: J Pain Symptom Manage Date: 2002-10 Impact factor: 3.612
Authors: Marit S Jordhoy; Gerd Inger Ringdal; Jorunn L Helbostad; Line Oldervoll; Jon Håvard Loge; Stein Kaasa Journal: Palliat Med Date: 2007-12 Impact factor: 4.762
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Jorunn L Helbostad; Line M Oldervoll; Peter M Fayers; Marit S Jordhøy; Kenneth C H Fearon; Florian Strasser; Stein Kaasa Journal: Support Care Cancer Date: 2010-03-26 Impact factor: 3.603
Authors: Natasja J H Raijmakers; M Zijlstra; J van Roij; O Husson; S Oerlemans; L V van de Poll-Franse Journal: Support Care Cancer Date: 2018-04-16 Impact factor: 3.603
Authors: Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy Journal: J Palliat Med Date: 2011-09-06 Impact factor: 2.947